Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: Results from a German registry (GRAID)

Journal of Rheumatology

Volumn 39, Issue 11, 2012, Pages 2153-2156

  Roll, Petra ^a   Ostermeier, Eva ^a   Haubitz, Marion ^b   Lovric, Svjetlana ^c   Unger, Leonore ^d   Holle, Julia ^e   Kötter, Ina ^f   Henes, Jörg C ^f   Bergner, Raoul ^g   Rubbert Roth, Andrea ^h   Specker, Christof ⁱ   Schulze Koops, Hendrik ^j   Müller Ladner, Ulf ^k   Fleck, Martin ^l   Burmester, Gerd Rüdiger ^m   Hiepe, Falk ^m   Heitmann, Stefan ⁿ   Aringer, Martin ^o   Fischer Betz, Rebecca ^p   Dörner, Thomas ^m   Tony, Hans Peter ^a   more..

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KLINIKUM FULDA   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e Klinikum Bad Bramstedt GmbH   (Germany)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g KLINIKUM LUDWIGSHAFEN   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ Eye Hospital   (Germany)

^j UNIVERSITY OF MUNICH   (Germany)

^k JUSTUS LIEBIG UNIVERSITY   (Germany)

^l UNIVERSITY OF REGENSBURG   (Germany)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁿ MARIENHOSPITAL STUTTGART   (Germany)

^o UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^p HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

Antineutrophil cytoplasmic antibody associated vasculitides; Efficacy; Rituximab; Safety

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; DISEASE REGISTRY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GERMANY; GRANULOMATOSIS; HERPES ZOSTER; HUMAN; INFECTION; INFUSION RELATED REACTION; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84868382114     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120482     Document Type: Article

References (12)

1. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Specks U, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;363:221-32.
2. Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B-lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:262-8.
3. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener's granulomatosis. Am J Respir Crit Care Med 2006;173:180-7.
4. Stasi R, Stipa E, Del Peota G, Amadori S, Newland AC, Provan D. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology 2006;4:1432-6.
5. Specks U, Fervenza FC, McDonald TJ, Hogan MC. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001;44:2836-40.
6. Tony HP, Burmester G, Schulze-Koops H, Grünke M, Henes J, Kotter I, et al. Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: Experience from a national registry (GRAID). Arthritis Res Ther 2011;13:R75.
7. Holle JU, Dubrau C, Herlyn K, Heller M, Ambrosch P, Noelle B, et al. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): Comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis 2012;71:327-33.
8. Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jaynde D. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: A cohort study. Clin Otolaryngol 2009;34:328-35.
9. Jones RB, Ferraro AJ, Chaudhry AN, Brogna P, Salama AD, Smith KGC, et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009;60:2156-68.
10. Seo P, Specks U, Keogh K. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations. J Rheumatol 2008;35:2017-23.
11. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
12. Jones RB, Tervaert JWC, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010;363:211-20.